CorneaGen - BostonDecember 20, 2024

FDA 483 - CorneaGen - Boston - December 20, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CorneaGen - Boston

Record Details

CorneaGen - Boston, a human tissue establishment, was cited for significant deficiencies related to donor eligibility and product distribution during an FDA inspection. The firm failed to properly determine ineligible donors with clinical evidence of sepsis and distributed corneas before completing donor eligibility determinations. These issues indicate a serious lapse in ensuring the safety and suitability of human tissue products.

Company: CorneaGen - Boston
Inspection Date: December 20, 2024
Product Type: Biologics
Office: New England District Office
Person: Anthony N. Onianwa (Investigator)

Open in Dashboard

ID · 8df31cfa-8379-47c9-8841-a09d6d074a37